Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Allara Health vs Spry

Allara Health
Graded #95

Higher grade

vs+14.400000000000006
Spry
Graded #408

Lower grade

The verdict

Allara Health takes it — 71.2/100 to 56.8/100.

Allara Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Allara Health (allarahealth.com) is an insurance-accepting telehealth platform focused on women's metabolic and hormonal health, including PCOS, serving 44 states plus DC.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAllara Health +14
68
54
Dose & formulationAllara Health +12
76
64
Clinical oversightAllara Health +30
85
55
Labs & monitoringAllara Health +9
61
52
FulfillmentAllara Health +9
70
61
Contract termsEven
55
55
Allara Health · left barSpry · right bar

The numbers

MetricAllara HealthSpry
WeighScore71.2/10056.8/100
GradeCC
Scorecard rank#95#408
Semaglutide$149/mo (plus a separate fee, brand-name)$199/mo (starting dose, compounded)
TirzepatideNot disclosed$299/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Allara Health

Graded #95 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound)
  • Accepts insurance with self-pay option from $149/month
  • Women's-health and PCOS specialization with hormonal/metabolic testing
  • Board-certified physicians, OB-GYNs, endocrinologists, plus dietitians
  • Oral alternatives (Metformin, Contrave, Topiramate) available

Where it loses points

  • Membership covers visits; GLP-1 medication coverage depends on your plan
  • Not available in all states for medical care
  • Focused on women's health, not a general GLP-1 provider
  • Out-of-pocket branded GLP-1 cost can be high if not insurance-covered
Spry

Graded #408 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard